Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Lisa Forman to Liver Transplantation

This is a "connection" page, showing publications Lisa Forman has written about Liver Transplantation.

 
Connection Strength
 
 
 
3.435
 
  1. Forman LM, Sapisochin G, Assis DN, Arriv? L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Reply: Living donor liver transplantation for people with PSC. Hepatology. 2023 05 01; 77(5):E97-E98.
    View in: PubMed
    Score: 0.507
  2. Yan K, Forman L. Cannabinoid Use Among Liver Transplant Recipients. Liver Transpl. 2021 11; 27(11):1623-1632.
    View in: PubMed
    Score: 0.458
  3. Francis P, Forman L. HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation. Liver Transpl. 2021 10; 27(10):1375-1377.
    View in: PubMed
    Score: 0.458
  4. Kalra A, Burton JR, Forman LM. Pro: Steroids Can Be Withdrawn After Transplant in Recipients With Autoimmune Hepatitis. Liver Transpl. 2018 08; 24(8):1109-1112.
    View in: PubMed
    Score: 0.373
  5. Forman LM. Metabolic syndrome in liver transplantation: the elephant in the room. Liver Transpl. 2008 Sep; 14(9):1245-8.
    View in: PubMed
    Score: 0.188
  6. Forman LM, Trotter JF, Emond J. Living donor liver transplantation and hepatitis C. Liver Transpl. 2004 Mar; 10(3):347-8.
    View in: PubMed
    Score: 0.137
  7. Forman LM, Lucey MR. Setting limits on selection of adults for liver transplantation. Transplantation. 2004 Jan 15; 77(1):19-21.
    View in: PubMed
    Score: 0.136
  8. Everson GT, Trotter JF, Kugelmas M, Forman L. Immunosuppression in liver transplantation. Minerva Chir. 2003 Oct; 58(5):725-40.
    View in: PubMed
    Score: 0.133
  9. Forman LM. To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis. 2003 Aug; 7(3):615-29.
    View in: PubMed
    Score: 0.132
  10. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. 2002 Apr; 122(4):889-96.
    View in: PubMed
    Score: 0.120
  11. Wilkey BJ, Hanson R, Reece TB, Forman L, Burton JR, Messenger JC, Kim MS, Cleveland JC, Fiegel MJ, Nydam TL, Mandell MS. Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child's Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report. Semin Cardiothorac Vasc Anesth. 2016 Jun; 20(2):158-62.
    View in: PubMed
    Score: 0.078
  12. Campos-Varela I, Lai JC, Verna EC, O'Leary JG, Todd Stravitz R, Forman LM, Trotter JF, Brown RS, Terrault NA. Hepatitis C genotype influences post-liver transplant outcomes. Transplantation. 2015 Apr; 99(4):835-40.
    View in: PubMed
    Score: 0.074
  13. Goldberg DS, Camp A, Martinez-Camacho A, Forman L, Fortune B, Reddy KR. Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis. Liver Transpl. 2013 Mar; 19(3):250-8.
    View in: PubMed
    Score: 0.064
  14. Biggins SW, Trotter J, Gralla J, Burton JR, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J Hepatol. 2013 May; 58(5):969-76.
    View in: PubMed
    Score: 0.064
  15. Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault NA. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012 May; 18(5):532-8.
    View in: PubMed
    Score: 0.061
  16. Lai JC, Verna EC, Brown RS, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA. Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology. 2011 Aug; 54(2):418-24.
    View in: PubMed
    Score: 0.057
  17. Weber NK, Forman LM, Trotter JF. HBIg discontinuation with maintenance oral anti-viral therapy and HBV vaccination in liver transplant recipients. Dig Dis Sci. 2010 Feb; 55(2):505-9.
    View in: PubMed
    Score: 0.052
  18. Heller JC, Prochazka AV, Everson GT, Forman LM. Long-term management after liver transplantation: primary care physician versus hepatologist. Liver Transpl. 2009 Oct; 15(10):1330-5.
    View in: PubMed
    Score: 0.051
  19. Campsen J, Zimmerman MA, Mandell MS, Wachs M, Bak T, Forman L, Steinberg T, Kam I. Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation. 2009 Jun 27; 87(12):1842-5.
    View in: PubMed
    Score: 0.050
  20. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75.
    View in: PubMed
    Score: 0.046
  21. Trotter JF, Campsen J, Bak T, Wachs M, Forman L, Everson G, Kam I. Outcomes of donor evaluations for adult-to-adult right hepatic lobe living donor liver transplantation. Am J Transplant. 2006 Aug; 6(8):1882-9.
    View in: PubMed
    Score: 0.041
  22. Slater K, Ludkowski M, Mehling J, Forman L, Pieramici E, Wachs M, Kam I, Bak T. Hepatic artery pseudoaneurysm - duodenal fistula after living donor liver transplant. Clin Transplant. 2004 Dec; 18(6):734-6.
    View in: PubMed
    Score: 0.036
  23. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004 Jan; 239(1):87-92.
    View in: PubMed
    Score: 0.034
  24. Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl. 2003 Nov; 9(11):1159-65.
    View in: PubMed
    Score: 0.034
  25. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 2003 Jul; 9(7):737-40.
    View in: PubMed
    Score: 0.033
  26. Everson GT, Trotter J, Forman L, Kugelmas M, Halprin A, Fey B, Ray C. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology. 2005 Aug; 42(2):255-62.
    View in: PubMed
    Score: 0.009
  27. Hayashi PH, Ludkowski M, Forman LM, Osgood M, Johnson S, Kugelmas M, Trotter JF, Bak T, Wachs M, Kam I, Durham J, Everson GT. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transplant. 2004 May; 4(5):782-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)